Professional Documents
Culture Documents
Innovations in Endodontics
Innovations in Endodontics
POWERED BY
INNOVATIONS IN
ENDODONTICS
MAY 2020
2 C E C R E D I T S
FORENSIC ENDODONTICS
Determining the
Correct Course
of Endodontic
Retreatment With
No Patient History
Available
James Bahcall, DMD, MS;
Qian Xie, DDS, PhD;
Mark Baker, DDS;
Steve Weeks, DDS; and
Daniel Oh, DDS, MS
S P E C I A L R E P O R T
Endodontic Pain
Management:
Preoperative,
Perioperative,
and Postoperative
Strategies
Brooke Blicher, DMD; and
Rebekah Lucier Pryles, DMD
SUPPORTED BY AN UNRESTRICTED GRANT FROM CARESTREAM DENTAL • Published by AEGIS Publications, LLC © 2020
Detecting
the Problem
of Continuing Education in Dentistry
A
PUBLISHER
Matthew T. Ingram
of Continuing Education in Dentistry
s clinicians, we don’t always have the benefit SPECIAL PROJECTS DIRECTOR
C. Justin Romano
of knowing a patient’s history. For example,
SPECIAL PROJECTS EDITOR
it is not uncommon for a patient to pres- Cindy Spielvogel
ent to the dental office with a problematic of Continuing Education in Dentistry
SPECIAL PROJECTS COORDINATOR
tooth that had previous endodontic treat- June Portnoy
• Define forensic endodontics • Identify the clinical steps • Describe the forensic
and how it differs from to determine the diagnosis endodontic retreatment
conventional endodontic and etiology of a patient’s options that may be provided
retreatment previously endodontically to the patient
treated tooth pain and/or
P
periradicular radiographic
lesion
is involved, the clinician should confirm with percussion, or palpation. Radiograph reveals
the patient that there is no referred pain from a periradicular radiolucency.
the maxilla to the mandibular jaw or vice versa Chronic apical abscess: Radiograph typi-
due to cold stimulus. Conversely, when a pa- cally reveals a periradicular radiolucency.
tient complains of sensitivity to hot stimulus, Clinically, a sinus tract is present on the gin-
the previously endodontically treated tooth in gival tissue. The draining sinus tract should
question should not be eliminated from etiol- be traced with a gutta-percha cone and then
ogy considerations. It has been reported that radiographed to confirm etiology and peri-
C-fibers can remain vital in the extreme api- odontal diagnosis.
cal portion of a root canal-treated tooth and, Acute apical abscess: This is an inflammatory
therefore, respond to a heat stimulus.4 reaction to pulpal infection and necrosis char-
While the pulpal diagnosis is an essential acterized by rapid onset, spontaneous pain, ex-
part of endodontic treatment prior to per- treme tenderness of the tooth to pressure, and
forming any root canal treatment or retreat- pus formation and swelling of associated tissues.
ment, a periradicular diagnosis is equally as Radiographic signs of osseous resorption may
important. A study by McCarthy et al demon- be present, and the patient often may experi-
strated that patients who presented with peri- ence malaise, fever, and/or lymphadenopathy.
radicular pain were better able to localize the
painful tooth (89%) in comparison to patients Effectiveness of CBCT
who presented with tooth pain without peri- CBCT can be used to aid in further assess-
radicular pain (30%).5 Current periradicular ment of a previously endodontically treated
diagnosis terminologies are as follows6: tooth. A study by Uraba et al demonstrated
Symptomatic apical periodontitis: The that CBCT imaging is 20% more effective in
tooth has a painful response to biting, palpa- detecting periapical lesions that cannot be
tion, and/or percussion; this may or may not detected on a periapical radiograph (Figure 1
be accompanied by radiographic changes. and Figure 2).7 Diagnostic CBCT can provide
Asymptomatic apical periodontitis: additional information in comparison to peri-
The tooth has no pain in response to biting, apical radiographs when treatment planning
Fig 1.
intentional replantation since it could be per- confirm correlation to the patient’s subjective
formed in one treatment visit. report of profound lower left lip anesthesia. The
A left inferior alveolar nerve block was admin- patient reported no pain to either percussion or
istered using 68 mg lidocaine with 0.01 mg/ml bite test on tooth No. 18 after the administration
epinephrine. A long buccal block, along with of local anesthesia.
an intraligamental injection around tooth No. After objective confirmation of profound left
18, was given with 17 mg Septocaine with 0.01 mandibular anesthesia, tooth No. 18 was ex-
mg/ml epinephrine. Objective pulpal testing tracted and wrapped in gauze saturated with
was performed with cold stimulus to confirm saline. Under a surgical microscope, the mesial
the level of pulpal anesthesia as correlated by and distal roots were resectioned 3 mm, and
the lack of patient’s subjective response to cold the root ends of both the mesial and distal roots
stimulus on tooth No. 19. Also, percussion and were stained with methylene blue and irrigat-
bite tests were performed on tooth No. 18 to ed with saline (Figure 6). Staining was noted
around gutta-percha, but
no fracture was observed
on either root. Root-end
ultrasonic preparation
was made 3 mm in depth
on the mesial and distal
roots, and placement of a
bioceramic root-end fill-
ing was completed.10 The
entire root-end prepara-
tion and root-end fill was
conducted outside the
Fig 6. Fig 7. mouth within a 10-minute
period.11 Also, during this
time the socket of tooth
No. 18 was gently curet-
ted to remove granulo-
matous-type tissue. Not
enough tissue could be re-
moved for a biopsy. Tooth
No. 18 was then properly
reseated in the exposed
socket (Figure 7) and su-
tured into place, and a fi-
nal periapical radiograph
Fig 8. Fig 9.
was taken (Figure 8).
The patient was given
Fig 6. Extracted tooth No. 18. Under surgical microscope, root-end resec- postoperative instruc-
tion and canal preparation were performed prior to placement of root- tions and medications
end bioceramic filling. Fig 7. Tooth No. 18 immediately after replacement (amoxicillin 500 mg,
in socket prior to suturing. Fig 8. Periapical radiograph of tooth No. 18
immediately after replacement in socket. Fig 9. Periapical radiograph of ibuprofen 600 mg, and
tooth No. 18 at 2-month recall appointment. chlorhexidine mouth
1. In forensic endodontics, the clinician must 6. The pulpal diagnosis in forensic endodontic
make a treatment assessment based only on: cases is:
A. how the patient currently presents. A. normal pulp.
B. past radiographs. B. previously treated.
C. r ecords from before the initial endodontic C. symptomatic irreversible pulpitis.
treatment. D. pulp necrosis.
D. existing CBCT scans.
7. McCarthy et al demonstrated that in
2. The clinician must determine the diagnosis comparison to patients who presented
and etiology of the tooth pain and/or without periradicular pain, patients with
radiographic lesion: periradicular pain:
A. before reviewing the patient’s medical and A. were less able to localize the painful
dental history. tooth.
B. b
efore performing any type of endodontic B. w
ere better able to localize the painful
retreatment. tooth.
C. after performing endodontic retreatment. C. were unable to localize the painful tooth at all.
D. after executing a forensic science D. were able to localize the painful tooth in
investigation. every situation.
3. Used in determining etiology, clinical 8. When the tooth has no pain in response
sensibility testing is considered to be: to biting, percussion, or palpation,
A. outdated. and radiograph reveals a periradicular
B. subjective. radiolucency, the diagnosis is:
C. objective. A. symptomatic apical periodontitis.
D. unnecessary. B. a symptomatic apical periodontitis.
C. c hronic apical abscess.
4. Clinical sensibility testing includes which of D. acute apical abscess.
the following?
A. cold test, electric pulp test, and/or hot test 9. Surgical retreatment can involve root-end
B. percussion testing resection/root-end filling, root amputation,
C. periodontal examination or, as was done in this case:
D. All of the above A. intentional replantation.
B. dental implant placement.
5. When documenting the results of sensibility C. gingival enlargement.
tests, the recommended data recording D. pulpal innervation.
method is the use of:
A. “+” and “-” symbols. 10. In the case presented, the patient had had a
B. subjective certification. previous root canal performed on tooth No. 18:
C. medical diagnostic terminology. A. 2 years ago by a dentist in the same town.
D. All of the above B. w ithin the past 3 years by a dentist in a
different state.
C. 5 years ago by a dentist whom the patient
knew.
D. many years ago by a dentist whom the
patient could not remember.
O
Brooke Blicher, DMD; and Rebekah Lucier Pryles, DMD
rofacial pain is often the impe- dosing, high safety profile, and ready availability
tus for patients to seek dental without a prescription. It functions by blocking
care, and endodontic disease the cyclooxygenase (COX) 1 and 2 enzymes to
accounts for a significant pro- prevent production of prostaglandins involved in
portion of this pain. That said, both pain transmission and inflammation.1 The
fear of pain during dental procedures is a maximum recommended dosage of ibuprofen
major deterrent for many prospective dental is 3200 mg/day, with common dosages ranging
patients. Thankfully, pain management strat- from 400 mg to 800 mg every 4 to 8 hours.2 Major
egies have significantly improved over time. side-effects include gastrointestinal upset and
Managing endodontic pain at all stages of di- are dose dependent; thus, the lowest effective
agnosis and treatment—preoperative, periop- dosage should be utilized.3
erative, and postoperative—may be achieved Furthermore, care must be exercised when
with a variety of evidence-based and reliable prescribing NSAIDs to patients with cardiac
pain management approaches. disease. A 30% increased risk of myocardial in-
The foundation of pain management is the de- farction is associated with exposure to ibuprofen
termination of pain source and development of in the 30 days prior to the event.4 These risks exist
a definitive diagnosis. Delivery of definitive care, even in patients who have taken ibuprofen for
either by endodontic therapy or extraction, is relatively short durations, particularly with dos-
the best way to provide complete relief of pain ages larger than 1200 mg/day.5 However, when
of endodontic origin.1 Beyond this, pain manage- compared to selective COX-2 inhibitors like ce-
ment should be considered prior to the provision lecoxib, NSAIDs, including ibuprofen, showed a
of definitive care, perioperatively while care is lesser risk of cardiovascular disease6; thus, they
being delivered, and postoperatively until signs remain the drug of choice, especially in patients
and symptoms of inflammation and infection re- with other cardiovascular risk factors.
solve. This article highlights evidence-based pain Acetaminophen functions to block prosta-
management strategies and briefly discusses the glandin synthesis peripherally and interacts
future direction of orofacial pain management. with cannabinoid and serotonergic receptors
centrally.7 The manufacturer’s maximum rec-
Preoperative Pain Management ommended dosage of acetaminophen is 3000
When definitive care cannot be delivered imme- mg/day. Given the risk of hepatoxicity associated
diately, oral analgesics offer convenient and ef- with acetaminophen, the lowest effective dosage
fective means to relieve even severe dental pain. is recommended.8
Over-the-counter oral analgesics include both Prescription oral analgesics include cortico-
nonsteroidal anti-inflammatory drugs (NSAIDs) steroids and opioid class drugs. Although they
and acetaminophen. Ibuprofen is the most stud- have shown efficacy in treating severe dental
ied drug in the NSAID class due to its convenient pain, corticosteroids like prednisalone and
anterior teeth may be successfully anesthe- patients with symptomatic irreversible pulpitis,
tized by infiltrations alone, whereas premolars although controversy exists.26-28
are most successfully anesthetized by the com-
bination of mental and inferior alveolar nerve Postoperative Pain Management
blocks (IANBs).17,18 Mandibular molars require While definitive treatment of endodontic pa-
block anesthesia, usually with the addition of an thology is the optimal means to alleviate severe
adjunctive anesthetic technique. Success rates pain, some degree of postoperative discomfort
of the IANB alone are quite low and alterna- is normal. Most patients report mild discomfort
tive block techniques, including the Gow-Gates after endodontic treatment with minimal impact
and Vazirani-Akinosi, show no greater effective- on daily living. Only 6% of patients report more
ness.18,19 Buccal infiltration with articaine exhib- acute pain following treatment, consistent with
its the greatest efficacy as an adjunct to the IANB a postoperative flare-up. Patients report resolu-
block, although other techniques, including tion of most pain symptoms within 2 to 3 days,
intraligamentary and intraosseous anesthesia, and 90% report complete pain relief by 1 week
are also effective.20 When all else fails, or when following endodontic treatment.29 Since post-
breakthrough sensitivity occurs mid-procedure, operative pain is common and to be expected,
intrapulpal anesthesia may be used.21 clinicians need to warn patients to anticipate its
In general, the type of anesthetic solution se- presence and arm them with strategies to mini-
lected does not appear to impact anesthetic suc- mize its impact. In addition to verbal communi-
cess. Both articaine and lidocaine provide equally cation, written instructions can effectively help
efficacious infiltration anesthesia.22 When con- manage patient expectations and clearly define
sidering block anesthesia, no differences have normal and abnormal conditions that may war-
been found in the efficacy of commonly available rant contacting an available emergency provider.
mepivacaine and lidocaine solutions.23 Articaine Like in the management of preoperative pain,
and other 4% solutions are discouraged for block oral medications, including combination therapy
anesthesia due to increased risks of paresthesia.24 with ibuprofen and acetaminophen, are most ap-
Adequate dosages of any of these drugs must propriate for the management of postoperative
be used to achieve profound pulpal anesthe- pain. Opioid class drugs are less effective and
sia, as a dose-response relationship exists. should be avoided if possible. Long-acting an-
Administration of 3.6 mL of anesthetic solution esthetics like bupivacaine are useful adjuncts
via IANB shows significantly fewer pulpal an- to ensure pain relief through the acute postop-
esthesia failures in mandibular molars than 1.8 erative period when pain can be most severe.
mL of solution.25 Bupivacaine possesses properties to provide
Local anesthesia alone may be insufficient for extended analgesia even beyond its half-life, ac-
perioperative pain control in some patients. In cording to studies in the medical literature.30
such cases, additional pharmacologic agents
may be used to increase its efficacy. Nitrous Future Considerations
oxide itself acts as an analgesic and can im- Areas of development to further improve pro-
prove the efficacy of local anesthetic solutions. found pulpal anesthesia include a promising
Benzodiazepines, however, do not potentiate the nasal spray that can anesthetize the maxillary
effects of local anesthetics, and should only be anterior sextant.18 Also, given the significance
expected to reduce procedure-related patient of opioid misuse, research will no doubt focus
anxiety. Preoperative use of oral analgesics, in- on the development of non-addictive alternative
cluding dexamethasone, NSAIDs, and tramadol, substances. Newer formulations of existing drugs
may improve effectiveness of IANB injections in may increase their bioavailability and potency.
ABOUT THE AUTHORS study in patients with osteoarthritis. Basic Clin Phar-
Brooke Blicher, DMD macol Toxicol. 2019;124(5):629-641.
Clinical Instructor, Department of Restorative Dentistry and 7. Yagiela JA, Neidle EA, Dowd FJ. Pharmacol-
Biomaterials Sciences, Harvard School of Dental Medicine, ogy and Therapeutics for Dentistry. St. Louis, MO:
Boston, Massachussetts; Assistant Clinical Professor, Mosby; 1998.
Department of Endodontics, Tufts University School 8. James LP, Mayeux PR, Hinson JA. Acetamino-
of Dental Medicine, Boston, Massachusetts; Diplomate, phen-induced hepatotoxicity. Drug Metab Dispos.
American Board of Endodontics; Private Practice limited to 2003;31(12):1499-1506.
Endodontics, White River Junction, Vermont 9. Shamszadeh S, Shirvani A, Eghbal MJ, Asgary S.
Efficacy of corticosteroids on postoperative end-
Rebekah Lucier Pryles, DMD odontic pain: a systematic review and meta-analysis.
Assistant Clinical Professor, Department of Endodontics, J Endod. 2018;44(7):1057-1065.
Tufts University School of Dental Medicine, Boston, 10. Richards D. The Oxford Pain Group League table
Massachusetts; Lecturer, Department of Restorative of analgesic efficacy. Evid Based Dent. 2004;5:22-23.
Dentistry and Biomaterials Sciences, Harvard School 11. Menhinick KA, Gutmann JL, Regan JD, et al. The
of Dental Medicine, Boston, Massachusetts; Diplomate, efficacy of pain control following nonsurgical root
American Board of Endodontics; Private Practice limited to canal treatment using ibuprofen or a combination
Endodontics, White River Junction, Vermont of ibuprofen and acetaminophen in a randomized,
double-blind, placebo-controlled study. Int Endod J.
2004;37(8):531-541.
REFERENCES 12. Derry CJ, Derry S, Moore RA. Single dose oral
1. Keiser K, Hargreaves KM. Building effective strate- ibuprofen plus paracetamol (acetaminophen) for
gies for the management of endodontic pain. Endod acute postoperative pain. Cochrane Database Syst
Topics. 2002;3:93-105. Rev. 2013;(6):CD010210.
2. Gage TW, Pickett FA. Mosby’s Dental Drug Refer- 13. Berman LH, Hartwell GR. Diagnosis. In: Harg-
ence. 7th ed. St Louis MO: Mosby; 2005. reaves KM, Cohen S, Berman LH, eds. Cohen’s Path-
3. Hargreaves KM, Troullos ES, Dionne RA. Pharma- ways of the Pulp. St Louis, MO: Mosby; 2011:2-39.
cologic rationale for the treatment of acute pain. 14. Aminoshariae A, Kulild JC. Evidence-based
Dent Clin North Am. 1987;31(4):675-694. recommendations for antibiotic usage to treat
4. Sondergaard KB, Gislason G. NSAIDs and cardiac endodontic infections and pain: a systematic review
arrest: non-steroidal anti-inflammatory drug use of randomized controlled trials. J Am Dent Assoc.
is associated with increased risk of out-of-hospital 2016;147(3):186-191.
cardiac arrest: a nationwide case-time-control study. 15. AAE position statement. AAE guidance on the
Eur Heart J. 2017;38(23):1788-1789. use of systemic antibiotics in endodontics. J Endod.
5. Bally M, Dendukuri N, Rich B, et al. Risk of acute 2017;43(9):1409-1413.
myocardial infarction with NSAIDs in real world use: 16. Aggarwal V, Singla M, Miglani S, et al. A prospec-
Bayesian meta-analysis of individual patient data. tive, randomized, single-blind comparative evalua-
BMJ. 2017;357:j1909. tion of anesthetic efficacy of posterior superior alve-
6. Barcella CA, Lamberts M, McGettigan P, et al. Dif- olar nerve blocks, buccal infiltrations, and buccal
ferences in cardiovascular safety with non-steroidal plus palatal infiltrations in patients with irreversible
anti-inflammatory drug therapy - a nationwide pulpitis. J Endod. 2011;37(11):1491-1494.